Amid coronavirus scare, India restricts export of 26 Active Pharmaceutical Ingredients
Amid coronavirus outbreak, the Directorate General of Foreign Trade (DGFT) has decided to restrict export of 26 Active Pharmaceutical Ingredients (API) in its revised export policy, due to concerns on the shortage of medicine in domestic markets.
- Country:
- India
Amid coronavirus outbreak, the Directorate General of Foreign Trade (DGFT) has decided to restrict export of 26 Active Pharmaceutical Ingredients (API) in its revised export policy, due to concerns on the shortage of medicine in domestic markets.
Meanwhile, with the spread of the coronavirus triggering risk-off sentiments, global financial markets have been experiencing considerable volatility.
As per the latest update, global deaths due to coronavirus outbreak on Monday rose to 3115. The deadly virus that originated in China's Wuhan late last year continues to spread around the world and has infected more than 90,000 people across 73 countries. (ANI)
ALSO READ
-
Japanese Lawmakers Visit India to See Worker Protection and Skills Projects in Action
-
Indian Unions Push for Fair Recruitment and Rights for Care Workers in Germany
-
Cleaner Kitchens, Polluted Skies: Hidden Health Cost of India’s Electricity Boom
-
Japan-Backed ILO Projects Help 23,000 Workers Gain Rights and Fight Child Labour
-
India's Delicate Balancing Act: Navigating Energy Security Amid Middle Eastern Tensions
Google News